Your browser doesn't support javascript.
loading
A risk classification model for prioritising the management of quality issues relating to substandard medicines in Singapore.
Ang, Pei San; Teo, Desmond Chun Hwee; Toh, Yi Long; Ng, Michelle Sau Yuen; Choong, Chih Tzer; Phuah, Doris Sock Tin; Tan, Dorothy Hooi Myn; Tan, Filina Meixuan; Tan, Maggie Siok Hwee; Koh, Suan Tian; Thinn, Wint Maw; Poh, Jalene Wang Woon; Dorajoo, Sreemanee Raaj.
Afiliação
  • Ang PS; Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Helios, Singapore.
  • Teo DCH; Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Helios, Singapore.
  • Toh YL; Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Helios, Singapore.
  • Ng MSY; Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Helios, Singapore.
  • Choong CT; Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Helios, Singapore.
  • Phuah DST; Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Helios, Singapore.
  • Tan DHM; Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Helios, Singapore.
  • Tan FM; Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Helios, Singapore.
  • Tan MSH; Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Helios, Singapore.
  • Koh ST; Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Helios, Singapore.
  • Thinn WM; Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Helios, Singapore.
  • Poh JWW; Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Helios, Singapore.
  • Dorajoo SR; Vigilance and Compliance Branch, Health Products Regulation Group, Health Sciences Authority, Helios, Singapore.
Pharmacoepidemiol Drug Saf ; 31(7): 729-738, 2022 07.
Article em En | MEDLINE | ID: mdl-35366030
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos Fora do Padrão Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Pharmacoepidemiol Drug Saf Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos Fora do Padrão Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Pharmacoepidemiol Drug Saf Ano de publicação: 2022 Tipo de documento: Article